Advertisement

Hematology and Oncology

Home Hematology and Oncology
Pathologists have wide variability in treatment suggestions for melanocytic lesions

Pathologists Vary in Suggested Therapy for Melanocytic Lesions

Variation may lead to undertreatment or overtreatment of melanocytic lesions
Health care provider burnout is negatively associated with quality and safety of health care

Health Care Provider Burnout Negatively Affects Quality, Safety

Health care provider burnout negatively linked to quality and safety of health care
MicroRNAs (miR-203 and miR-205) could be useful prognostic markers in cutaneous squamous cell carcinoma

MicroRNAs 203 and 205 Are Prognostic in Cutaneous SCC

miR-205 expression in tumors with pathologic features indicating poor prognosis, in invasion front
Regular aspirin use is associated with reduced risk of pancreatic cancer in a Chinese cohort

Regular Aspirin Use Linked to Reduced Risk of Pancreatic CA

Ever-regular use associated with lowered risk, with 8 percent decrease for each cumulative year of use
For nonmetastatic nasopharyngeal carcinoma

Adjuvant Chemo Plus CRT Best in Nasopharyngeal Carcinoma

Highest survival benefit for addition of AC to CRT, with consistent improvement for all end points
For hepatitis C virus-infected patients

Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C

Diabetes increases risk of hepatocellular carcinoma development in patients with HCV
Cancer patients who have diabetes may suffer worse heart damage from chemotherapy

Chemo-Related Cardiotoxicity Worse in Diabetes Patients

Those with diabetes showed more early warning signs of heart failure
For patients who received transfusions in Sweden and Denmark from 2003 to 2012

No Link for Transfused Red Blood Cell Storage, Mortality

No link for length of red blood cell storage, mortality in transfusion recipients from Sweden, Denmark
The Drug Enforcement Administration has announced critical changes in its registration renewal process

DEA Announces Critical Changes in Registration Renewal Process

The ability to renew a registration online after the expiration date will no longer be available
The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

Rubraca's use is specific to women with deleterious BRCA mutations